Regulation of stromal proliferation, growth arrest, differentiation and apoptosis in benign prostatic hyperplasia by TGF-β

Frontiers in Bioscience

Volumn 8, Issue SUPPL., 2003, Pages

  Huang, Xuemei ^a   Lee, Chung ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Benign prostatic hyperplasia (BPH); Differentiations and Apoptosis; Extracellular matrix (ECM); Growth Arrest; Proliferation; Prostate Stromal Cells; Review; Transforming Growth Factor beta (TGF )

Indexed keywords

COLLAGEN; INTEGRIN; TESTOSTERONE; TRANSFORMING GROWTH FACTOR BETA;

ACTIN FILAMENT; APOPTOSIS; CANCER SUSCEPTIBILITY; CELL AGING; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TYPE; EXTRACELLULAR MATRIX; GROWTH INHIBITION; HUMAN; IMMUNOCYTOCHEMISTRY; MITOSIS INHIBITION; PROSTATE HYPERTROPHY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS REGULATION; REVIEW; SMOOTH MUSCLE FIBER; TESTIS CELL; TESTOSTERONE RELEASE; UPREGULATION; ANIMAL; MALE; PATHOLOGY; PHYSIOLOGY; STROMA CELL;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; HUMANS; MALE; PROSTATIC HYPERPLASIA; STROMAL CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 4344716093     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: None     Document Type: Review

References (108)

1. Franks LM: Benign nodular hyperplasia of the prostate. Ann R Coll Surg 14, 92-106 (1954)
2. Berry SJ, DS Coffey, PC WALSH, LL Ewing: Development of human benign prostatic hyperplasia with age. Journal of Urology 132, 474 (1984)
3. Isaacs JT, DS Coffey: Etiology and disease process of benign prostatic hyperplasia. Prostate Suppl 2, 33-50 (1989)
4. Moore RA: Benign Hyperplasia of the Prostate: A morphologic study. Journal of Urology 50, 680 (1943)
5. Wu JP, FL Gu: The prostate 41-65 years post castration: An analysis of 26 eunuchs. Chinese Med J 100, 271-272 (1987)
6. McNeal JE: Normal histology of the prostate. Am J Surg Pathol 12, 619-633 (1988)
7. Grayhack JT, JM Kozlowski, C Lee: The pathogenesis of BPH: A proposed hypothesis and critical evaluation. Journal of Urology 160, 2375-2380 (1998)
8. Kong X, L Zeng, Y Yang, T Xia, F Gu, Y Guo, C Lee: Immunohistochemical characterization of stromal nodules in benign prostatic hyperplasia. The Prostate Journal 2, 199-204 (2000)
9. Lee C, JM Kozlowski, JT Grayhack: intrinsic and extrinsic factors controlling benign prostatic growth. Prostate 31, 131-138 (1997)
10. Janulis J, C Lee: The prostate gland. In: Encyclopedia of Reproduction. Eds: Knobil E, Neil J. Volume 4 New York: Academic Press, 77-85 (1999)
11. Lee C, A Cockett, O Cussenot, K Griffiths, W Isaacs, J Schalken, R Buttyan, G Prins, G Steiner: Regulation of prostate growth. In: Benign Prostatic Hyperplasia. Eds: Chatelain C, L Denis, KT Foo, S Khoury, J McConnell. Plymbridge Distributors Ltd, Plymouth, UK 81-106 (2001)
12. Shapiro E, V Hartano, H Lepor: Anti-desmin vs. anti-actin for quantifying the area density of prostate smooth muscle. Prostate 20, 259-267 (1992)
13. Bierhoff E, J Vogel, M Benz, T Giefer, N Wernert, U Pfeifer: Stromal nodules in benign prostatic hyperplasia. Eur Urol 29, 345-267 (1996)
14. Van der Loop FTL: Smoothlin, a novel cytoskeletal protein specific for smooth muscle cells. J Cell Biol 134, 401-411 (1996)
15. Levine AC, M Ren, GK Huber, A Kirschenbaum: The effect of androgen, estrogen and growth factors on proliferation of cultured fibroblasts derived from human fetal and adult prostates. Endocrinology 130, 2413-2419 (1992)
16. Kooistra A, NMJ Elissen, JJ Konig, M Vermey, TH van der Kwast, JC Romjen, FH Schroder: Immunocytochemical characterization of explant cultures of human prostatic stromal cells. Prostate 27, 42-49 (1995)
17. Zhang J, M Hess, M Thurnher, A Hobbisch, C Radmayer, M Cronauer, A Hittmair, Z Culig, G Bartsch, H Klocker: Human prostatic smooth muscle cells in culture: Estradiol enhances expression of smooth muscle cell-specific markers. Prostate 30, 117-129 (1997)
18. Peehl DM, RG Sellers: Induction of smooth muscle cell phenotype in cultured human prostatic stromal cells. Exp Cell Res 232, 208-215 (1997)
19. Kassen A, DM Sutkowski, HJ Ahn, JA Sensibar, J M Kozlowski, C Lee: Stromal cells of human prostate: Initial isolation and characterization. Prostate 28, 89-97 (1996)
20. Sensibar JA, SJ Pruden, RZ Kasjanski, A Rademaker, C Lee, C Grayhack, JM Kozlowski: Differential growth rates in stromal cultures of the human prostate derived from varying patient ages. Prostate 38, 110-117 (1999)
21. Lee C, SM Sintich, EP Mathews, AH Shah: Transforming Growth Factor-beta in Benign and Malignant Prostate. Prostate 39, 285-290 (1999)
22. Slater M, JA Barden, CR Murphy: Changes in growth factor expression in the ageing prostate may disrupt epithelial-stromal homeostasis. Histchem J 32, 357-364 (2000)
23. Marks LS, B Treiger, FJ Dorey, YS Fu, JB DeKernion: Morphometry of the prostate: I. Distribution of tissue components in hyperplastic glands. Urology 44, 486-492 (1994)
24. Lee C: Role of androgen in prostatic growth and regression: Stromal-epithelial interaction. Prostate Suppl 6, 52-56 (1996)
25. Rand HW: A contribution to the surgery of hypertrophied prostate. Ann Surg 22, 1-80 (1895)
26. Zhou ZX, CI Wong, M Sar, EM Wilson: The androgen receptor: An overview. Rec Prog Horm Res 49, 249-274. (1994)
27. Cunha GR, H Fujii, BL Neubauer, JM Shannon, L Sawyer, BA Reese: Epithelial-mesenchymal interactions in prostatic development. Morphological observations of prostatic induction by urogenital sinus mesenchyme in epithelium of the adult rodent urinary bladder. J Cell Biol 96, 662-1670 (1983)
28. Hayward SW, GR Cunha, R Dahiya: Normal development and carcinogenesis of the prostate. Ann NY Acad Sci 784, 50-62 (1996)
29. Bruchovsky N, JD Wilson: The conversion of testosterone to 5α-androstan-17β-ol-3-one by rat prostate in vivo and in vitro. J Biol Chem 243, 2012-2021 (1968)
30. Anderson KM, S Liao: Selective retention of dihydrotestosterone by prostatic nuclei. Nature 219, 277-279 (1968)
31. Stoner E: The clinical effects of a 5α-reductase inhibitor, finasteride, on benign prostatic hyperplasia. J Urol 147, 1298-1302 (1992)
32. Kozak I, W Bartsch, M Krieg, K Voight. Nuclei of stroma: Site of highest estrogen concentration in human benign prostatic hyperplasia. Prostate 3, 433-438 (1982)
33. Krieg M, R Nass, S Tunn: Effect of aging on endogenous level of 5α-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate. J Clin Endocrinol Metab 77, 375-381 (1993)
34. Schultze H, E Barrack: Immunocytochemical localization of estrogen receptors in the normal male and female canine urinary tract and prostate. Endocrinology 121, 1773-1783 (1987)
35. Schultze H, S Claus: Histological localization of estrogen receptors in normal and diseased human prostates by immunocytochemistry. Prostate 16, 331-343 (1990)
36. Coffey D, P Walsh: Clinical and experimental studies of benign prostatic hyperplasia. Urol Clin North Am 17, 461-475 (1990)
37. Zhang J, I Park, Y Cheng, H Klocker, C Lee: Estradiol enhances TGF-beta1 expression and its secretion levels in human prostatic stromal cells. Proceedings of the Annual Meeting of the American Urological Association, Orlando, FL, May 25-30 (Abst # 856) (2002a)
38. Zhang J, I Park, J Li, H Klocker, C Lee: The conditional medium of LNCaP cell line stimulates aromatase expression in prostatic stromal cells. Proceedings of the Annual Meeting of the American Urological Association, Orlando, FL, May 25-30 (Abst # 858) (2002b)
39. Rohr HP, G Bartsch: Human benign prostatic hyperplasia: a stromal disease. Urology 16, 625-633 (1980)
40. Theyer G, G Kramer, I Assmann, E Sherwood, W Preinfalf, M Marberger, O Zechner, GE Steiner: Phenotype characterization of infiltrating leukocytes in benign prostatic hyperplasia. Lab Invest 66, 96-107 (1992)
41. Deering RE, SA Bigler, M Brown, MK Brawer: Microvascularity in benign prostatic hyperplasia. Prostate 26, 111-115 (1995)
42. McVary KT, KE McKanna, C Lee: Prostate innervation. Prostate Supplement 8, 2-13 (1998)
43. 1 adrenergic receptor in human benign prostatic hyperplasia. J Urol 150, 2002-2006 (1984)
44. 1 adrenergic receptors in the lower genitourinary tissues: insight into development and function. J Urol 138, 979-983 (1987)
45. Liu AY, L La Tray, G van den Engh: Changes in cell surface molecules associated with in vitro culture of prostatic stromal cells. Prostate 45, 303-312 (2000)
46. Sherwood ER, C-J Fong, C Lee, JM Kozlowski: Basic fibroblast growth factor: A potential mediator of stromal growth in the human prostate. Endocrinology 130, 2955-2963 (1992)
47. Peehl DM, RG Sellers: Basic FGF, EGF, and PDGF modify TGF-β-induction of smooth muscle cell phenotype in human prostatic stromal cells. Prostate 35, 125-134 (1998)
48. Derynck R, JA Jarret, EY Chen, DH Eaton, JR Bell, RK Assoian, AB Roberts, MB Sporn, DV Geoddel: Human transforming growth factor-beta complementary DNA sequences and expression in normal and transformed cells. Nature 316, 701-705 (1985)
49. Madison L, NR Webb, TM Rose, H Marquardt, T Ikeda, D Twardzik, S Seyedin, AF Purchio: Transforming Growth Factor-beta2: cDNA cloning and sequence analysis. DNA 7, 1-8 (1988)
50. Itoh N, U Patel, AS Cupp, MK Skinner: Developmental and hormonal regulation of transforming growth factor-β1 (TGF-β1), -2, and -3 gene expression in isolated prostatic epithelial and stromal cells: Edidermal growth factor and TGF-β interactions. Endocrinology 139, 1378-1388 (1998)
51. Klingler HC, AJ Bretland, SV Reid, CR Chapple, CL Eaton: Regulation of prostatic stromal cell growth by transforming growth factor beta (TGFβ). Prostate 41, 110-120 (1999)
52. Timme TL, LD Truong, VW Merz, T Krebs, D Kadmon, KC Flanders, SH Park, TC Thompson: (1994) Mesenchymal epithelial interactions and transforming growth factor-β expression during mouse prostate morphogenesis. Endocrinology 134, 1039-1045.
53. Miyazono K, U Hellman, C Wernstedt, CH Heldin: Latent high molecular complex of transforming growth factor β1. J Biol Chem 263, 6407-6415 (1988)
54. Lyons RN, J Keski-Oja, HL Moses. Proteolytic activation of latent transforming growth factor β from fibroblast conditioned medium. J Cell Biol 106, 1659-1665 (1988)
55. Robert AB and MB Sporn: The Transforming Growth Factor-betas. In: Peptide growth factors and their receptors, part I, Vol. 95. Eds: Sporn MB, Roberts AB, Berlin: Springer-Verlag 419-472 (1990)
56. Ten Dijke P, G Marie-jose, F Itoh, S Itoh. Regulation of Cell Proliferation by Smad Proteins. Journal of Cellular Physiology 2002, 191:1-16
57. Cheifetz S, H Hernandez, M Laiho, P Ten Dijke, KK Iwata, J Massague: Distinct Transforming Growth Factor-beta receptor subsets as determinants of cellular responsiveness to three TGF-beta isoforms. J Biol Chem. 165, 20533-20538 (1990)
58. Cheifetz S, N Ling, R Guilemin, J Massague: A surface component on GH3 pituitary cells that recognizes that recognizes Transforming Growth Factor-beta, actin and inhibin. J Biol Chem 263, 17225-17228 (1988)
59. Lopez-Casillas F, JL Wrana, J Massague: Betaglycan presents ligand to the TGF signaling receptor. Cell 73, 1435-1444 (1993)
60. Rodriguez C, F Chen, RA Weinberg, HF Lodish: Cooperative binding of Transforming Growth Factor-beta2 to the TβR-1 and II TGF-beta receptors. J Biol Chem 27, 15919-15922 (1995)
61. Sankar M, N Mahooti-Brooks, M Centrella, TH McCarthy, JA Madri: Expression of Transforming Growth Factor TβR-III receptor in vascular endothelial cells increase their responsiveness to transforming growth Factor 2. J Biol Chem 270, 2769-2775 (1995)
62. Kingsley DM: The TGF-β Superfamily: new members, new receptors, and new genetic tests of function in different organisms (review). Genes Dev 8, 133-146 (1994)
63. Wrana JL, L Attisan, R Wieser, F Ventura, J Massagué: Mechanism of activation of the TGF-beta receptor. Nature 370, 341-347 (1994)
64. Massagué J: TGF-beta signal Transduction. Ann Rev Biochem 67, 753-91 (1998)
65. Massagué J: How Cells read TGF-beta signals. Nature Rev Mol Cell Biol 1, 169-178 (2000a)
66. Massagué J: TGF-beta signal in Growth Control, Cancer, and Heritable Disorders. Cell 103, 295-309 (2000b)
67. Nemeth JA, JA Sensibar, RR White, DJ Zelner, IY Kim, C Lee: Prostatic ductal system in rats: Tissue-specific expression and regional variation in stromal distribution of transforming growth factorβ1. Prostate 33, 64-71 (1997)
68. Kundu SD, IY Kim, T Yang, L Doglio, S Lang, X Zhang, R Buttyan, SJ Kim, J Chang, X Cai, Z Wang, C Lee: Absence of proximal duct apoptosis in the ventral prostate of transgenic mice carrying C3(1)-TGF-β type II dominant receptor. Prostate 43, 118-124 (2000)
69. Park I, W Zhou, SY Kimm, M Pins, JM Kozlowksi, B Jovanovic, J Zhang, C Lee, K Ilio: Dual regulation of proliferation and growth arrest in prostatic stromal cells by transforming growth factor-β1. (Submitted in 2002)
70. Moses HL, EY Yang, JA Pietenpol: TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63, 245-247 (1990)
71. Lio KY, II Park, MR Pins, JM Kozlowski, C Lee: Apoptotic activity of Doxazosin on prostate stroma in vitro is mediated through an autocrine expression of TGF-β1. Prostate 48, 131-135 (2001)
72. Moses HL, Jr RL Coffey, EB Leof: Transforming growth factor β regulation of cell proliferation. J Cell Physiol (suppl) 5, 1-7 (1987)
73. Sintich SM, MLG Lamm, JA Sensibar, C Lee. Transforming growth factor-β1 induced proliferation of the prostate cancer cell line, TSU-Pr1: The role of platelet-derived growth factor. Endocrinology 140, 3411-3415, (1999)
74. Facchini IM, IZ Penn. (1998) The molecular role of Myc in growth and transformation: recent discoveries lead to new insights. FASEB J 12, 633-651.
75. Dang CV: c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 19, 1-11 (1999)
76. Taylor LM, LM Khachigian: Induction of platelet-derived growth factor B-chain expression by transforming growth factor-β involves transactivation by Smads. J Biol Chem 275, 16709-16716 (2000)
77. INK4b is a potential effector of cell cycle arrest mediated by TGF-β. Nature 371, 257-261 (1994).
78. kip1 coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev 11, 492-503 (1997)
79. Eilers M, S Schirm, and JM Bishop: The MYC protein activates transcription of the $-prothymosin gene. EMBO J. 10, 133-141 (1991)
80. Askew DS, RA Ashmun, BC Simmons, and JL Cleveland: Competitive expression in an IL-3 dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6, 1915-1922 (1991)
81. Evan GI, AH Wyllie, CS Gilbert, TD Littlewood, H Land, M Brooks, CM Waters, LZ Penn, and DC Hancock: Induction of apoptosis in fibroblasts by c-myc protein. Cell 69, 119-128 (1992)
82. Henriksson M, B Lüscher: Proteins of the myc network: Essential regulators of cell growth and differentiation. Cancer Res 68, 109-182 (1996)
83. Lemaitre JM, RS Buckle, and M Mechali: c-Myc in the control of cell proliferation and embryonic development. Adv Cancer Res 70, 96-144 (1996)
84. Sherr CJ, and Roberts: CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13, 1501-1512 (1999)
85. Roberts AB, MB Sporn, RK Assoian: The Transforming Growth Factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vivo. Proc Natl Acad Sci USA 83, 4167-4171 (1986)
86. Ignotz RA, J Massague: Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261, 4337-4345 (1986)
87. Edwards DR, G Murphy, JJ Reynolds: Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 6, 1899-1904 (1987)
88. Verrecchia F, A Mauviel: Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation. Invest Dermatol 118, 211-215 (2002)
89. Rossi P, G Karsenty, AB Roberts, NS Roche, MB Sporn, B de Crombrugghe: A nuclear factor I binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-beta. Cell 52, 405-414 (1988)
90. Ritzenthaler JD, RH Goldstein, A Fine, A Lichtler, DW Rowe, BD Smith: Transforming growth factor beta activation elements in the distal promoter regions of the rat alpha 1 type I collagen gene. Biochem J 280, 157-162 (1991)
91. Ritzenthaler JD, RH Goldstein, A Fine, BD Smith: Regulation of the alpha 1(I) collagen promoter via a transforming growth factor-beta activation element. J Biol Chem 268, 13625-13631 (1993)
92. Inagaki Y, S Truter, F Ramirez: Transforming growth factor-beta stimulates alpha 2(I) collagen gene expression through cis-acting element that contains a Sp-1-binding site. J Biol Chem 269, 14828-14834 (1994)
93. Chung KY, A Agarwal, J Uitto, A Mauviel: An AP-1 binding sequence is essential for regulation of the human alpha 2(I) collagen (COL1A2) promoter activity by transforming growth factor-beta. J Biol Coffey D, Walsh P: Clinical and experimental studies of benign prostatic hyperplasia. Urol Clin North Am 17, 461-475 (1990)
94. Chung KY, A Agarwal, J Uitto, A Mauviel: An AP-1 binding sequence is essential for regulation of the human alpha 2(I) collagen (COL1A2) promoter activity by transforming growth factor-beta. J Biol Coffey D, Walsh P: Clinical and experimental studies of benign prostatic hyperplasia. Urol Clin North Am 17, 461-475 (1990)
95. Fukabori Y, K Nakano, A Ohyama, H Yamanaka: Stimulatory effect of transforming growth factor-β on collagen synthesis by human prostatic stromal cells in vitro. Int J Urol 4, 597-602 (1997)
96. Yokoi H, M Mukoyama, A Sugawara, K Mori, T Nagae, H Makino, T Suganami, K Yahata, Y Fujinaga, I Tanaka, K Nakao: Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis. Am J Physiol Renal Physiol 282, F933-F942 (2002)
97. Hay ED: Cell Biology of Extracellular Matrix. New York: Plenum Press (1981)
98. Watt FM: The extracellular matrix and cell shape. TIBS 11, 482-485 (1986)
99. Adams JC, FM Watt: Regulation of development and differentiation by extracellular matrix. Develop 117, 1183-1198 (1993)
100. Rupp PA, CD Little: Integrins in vascular development. Circ Res 89, 566-572 (2001)
101. Yao CC, J Breuss, R Pytela, RH Kramer: Functional expression of the alpha 7 integrin receptor in differentiated smooth muscle cells. J Cell Sci 110, 1477-1487 (1997)
102. Wayner EA, WG Carter: Identification of multiple cell adhesion receptors for type VI collagen and fibronectin in human fibrosarcoma cells possessing unique α and common β1 subunit. J Cell Biol 105, 1873-1884 (1987)
103. Arora PD, N Narani, CAG McCulloch: The compliance of collagen gels regulates transforming growth factor-β induction of smooth muscle α-actin in fibroblasts. Am J Pathol 154, 871-882 (1999)
104. Graham A, G Koentges, and A Lumsden: Neural crest apoptosis and the establishment of cranofacial pattern: an honorable death. Mol Cell Neurosci 8, 76-83 (1996)
105. Nguyen AV and JW Pollard: Transforming growth factor β 3 induces cell death during the first stage of mammary gland involution. Devel 127:3107-3118 (2000).
106. Kyprianou N, JP Litvak, A Borkowski, R Alexander, SC Jacobs. Induction of prostate apoptosis by doxazosin in benign prostatic hyperplasia. J Urol 159, 1810-1815 (1998)
107. Chon JK, A Borkowski, AW Partin, JT Isaacs, SC Jacobs, N Kyprianou: Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia. J Urol 161, 2002-2008 (1999)
108. Yao CC, J Breuss, R Pytela, RH Kramer: Functional expression of the alpha 7 integrin receptor in differentiated smooth muscle cells. J Cell Sci 110, 1477-1487 (1997)